The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Self-citationIKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,296
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Endoplasmic Reticulum Stress Signaling in Disease
Marciniak, S. J., & Ron, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2006 · Cited by 945
Splanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
Moschen, A. R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., & Tilg, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1748 · Cited by 933
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911
The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Utzschneider, K. M., & Kahn, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0587 · Cited by 856
βAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance
Bachman, E. S., Dhillon, H., Zhang, C.-Y., Cinti, S., Bianco, A. C., Kobilka, B. K., & Lowell, B. B. (2002) · Science · doi:10.1126/science.1073160 · Cited by 783
Oxidative stress-related molecules and liver fibrosis
Parola, M., & Robino, G. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00142-8 · Cited by 783
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Self-citationCYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753
Crespo, J., Cayón, A., Fernández-Gil, P., Hernández-Guerra, M., Mayorga, M., Domínguez-Díez, A., Fernández-Escalante, J. C., & Pons-Romero, F. (2001) · Hepatology · doi:10.1053/jhep.2001.29628 · Cited by 693
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.068 · Cited by 629
Szabó, C., Zingarelli, B., O'Connor, M., & Salzman, A. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1753 · Cited by 622
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608
Haukeland, J. W., Damås, J. K., Konopski, Z., Løberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjøro, K., & Aukrust, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.011 · Cited by 603
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Reactions between nitric oxide and haemoglobin under physiological conditions
Gow, A. J., & Stamler, J. S. (1998) · Nature · doi:10.1038/34402 · Cited by 574
Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 548
Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance
Matsuzaka, T., Shimano, H., Yahagi, N., Kato, T., Atsumi, A., Yamamoto, T., Inoue, N., Ishikawa, M., Okada, S., Ishigaki, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1662 · Cited by 542
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Apoptosis: The nexus of liver injury and fibrosis
Canbay, A., Friedman, S., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 527
Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., & Wakasa, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00073-9 · Cited by 521
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.029 · Cited by 479
Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3075 · Cited by 469
Self-citationKoteish, A., & Diehl, A. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12932 · Cited by 445
Bugianesi, E., Pagotto, U., Manini, R., Vanni, E., Gastaldelli, A., de Iasio, R., Gentilcore, E., Natale, S., Cassader, M., Rizzetto, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2240 · Cited by 408
Self-citationToll-Like Receptor Signaling in the Liver
Schwabe, R. F., Seki, E., & Brenner, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.038 · Cited by 401
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384
Attenuation of leptin and insulin signaling by SOCS proteins
Howard, J. K., & Flier, J. S. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.09.007 · Cited by 370
Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343
Aleffi, S., Petrai, I., Bertolani, C., Parola, M., Colombatto, S., Novo, E., Vizzutti, F., Anania, F. A., Milani, S., Rombouts, K., et al. (2005) · Hepatology · doi:10.1002/hep.20965 · Cited by 342
Self-citationSvegliati-Baroni, G., Ridolfi, F., Di Sario, A., Casini, A., Marucci, L., Gaggiotti, G., Orlandoni, P., Macarri, G., Perego, L., Benedetti, A., et al. (1999) · Hepatology · doi:10.1002/hep.510290632 · Cited by 320
Self-citationXu, Z., Chen, L., Leung, L., Yen, T. S. B., Lee, C., & Chan, J. Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500660102 · Cited by 292
Yesilova, Z., Yaman, H., Oktenli, C., Ozcan, A., Uygun, A., Cakir, E., Sanisoglu, S. Y., Erdil, A., Ates, Y., Aslan, M., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41500.x · Cited by 289
dela Peña, A., Leclercq, I., Field, J., George, J., Jones, B., & Farrell, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.004 · Cited by 287
Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
Tamura, S., & Shimomura, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524930 · Cited by 287
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
Adipokines in NASH: Postprandial Lipid Metabolism as a Link Between Adiponectin and Liver Disease *
Musso, G., Gambino, R., Durazzo, M., Biroli, G., Carello, M., Fagà, E., Pacini, G., De Michieli, F., Rabbione, L., Premoli, A., et al. (2005) · Hepatology · doi:10.1002/hep.20896 · Cited by 271
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., De Minicis, S., Nobili, L., Salzano, R., Omenetti, A., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050953 · Cited by 256
Self-citationA Genomic and Proteomic Study of the Spectrum of Nonalcoholic Fatty Liver Disease *
Younossi, Z. M., Baranova, A., Ziegler, K., Del Giacco, L., Schlauch, K., Born, T. L., Elariny, H., Gorreta, F., VanMeter, A., Younoszai, A., et al. (2005) · Hepatology · doi:10.1002/hep.20838 · Cited by 230
Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
Leclercq, I. A., Farrell, G. C., Sempoux, C., Peña, A. D., & Horsmans, Y. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.010 · Cited by 224
Sumida, Y., Nakashima, T., Yoh, T., Furutani, M., Hirohama, A., Kakisaka, Y., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Okanoue, T., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00331-8 · Cited by 215
Hong, F., Radaeva, S., Pan, H.-N., Tian, Z., Veech, R., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.1840400424 · Cited by 202
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice
García-Ruiz, I., Rodríguez-Juan, C., Díaz-Sanjuan, T., del Hoyo, P., Colina, F., Muñoz-Yagüe, T., & Solís-Herruzo, J. A. (2006) · Hepatology · doi:10.1002/hep.21313 · Cited by 189
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Gervois, P., Fruchart, J.-C., & Staels, B. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0397 · Cited by 161
Rahman, S. M., Schroeder‐Gloeckler, J. M., Janssen, R. C., Jiang, H., Qadri, I., Maclean, K. N., & Friedman, J. E. (2007) · Hepatology · doi:10.1002/hep.21614 · Cited by 159
Bajaj, M., Suraamornkul, S., Hardies, L. J., Pratipanawatr, T., & DeFronzo, R. A. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802625 · Cited by 159
Fehrenbach, H., Weiskirchen, R., Kasper, M., & Gressner, A. M. (2001) · Hepatology · doi:10.1053/jhep.2001.28788 · Cited by 154
Resistin as an Intrahepatic Cytokine
Bertolani, C., Sancho‐Bru, P., Failli, P., Bataller, R. A., Aleffi, S., DeFranco, R., Mazzinghi, B., Romagnani, P., Milani, S., Ginès, P., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060081 · Cited by 153
Self-citationIkura, Y., Ohsawa, M., Suekane, T., Fukushima, H., Itabe, H., Jomura, H., Nishiguchi, S., Inoue, T., Naruko, T., Ehara, S., et al. (2006) · Hepatology · doi:10.1002/hep.21070 · Cited by 152
Brun, P., Castagliuolo, I., Pinzani, M., Palù, G., & Martines, D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2004 · Cited by 147
Resistin: yet another adipokine tells us that men are not mice
Arner, P. (2005) · Diabetologia · doi:10.1007/s00125-005-1956-3 · Cited by 144
NADPH Oxidase in the Liver: Defensive, Offensive, or Fibrogenic?
Minicis, S. D., Bataller, R. A., & Brenner, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.048 · Cited by 121
Paradies, G., Ruggiero, F. M., Gadaleta, M. N., & Quagliariello, E. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90103-s · Cited by 112
The Effect of Pioglitazone on the Liver
Gastaldelli, A., Miyazaki, Y., Mahankali, A., Berria, R., Pettiti, M., Buzzigoli, E., Ferrannini, E., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2445 · Cited by 94
Self-citationSánchez-Alcázar, J. A., Schneider, E., Martı́nez, M. A., Carmona, P., Hernández‐Muñoz, I., Siles, E., de la Torre, P., Ruíz-Cabello, J., García‐Ruíz, I., & Solis-Herruzo, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13353 · Cited by 93
Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis
Ramalho, R. M., Cortez‐Pinto, H., Castro, R. E., Sol, S., Costa, A. L., de Moura, M. C., Camilo, M., & Rodrigues, C. L. M. P. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00005 · Cited by 93
The Effect of Rosiglitazone on the Liver: Decreased Gluconeogenesis in Patients with Type 2 Diabetes
Gastaldelli, A., Miyazaki, Y., Pettiti, M., Santini, E., Ciociaro, D., DeFronzo, R. A., & Ferrannini, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1159 · Cited by 76
Self-citationResistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo
Fishman, S., Muzumdar, R. H., Atzmon, G., Ma, X., Yang, X., Einstein, F. H., & Barzilai, N. (2006) · The FASEB Journal · doi:10.1096/fj.06-6557com · Cited by 74
WATANABE, S., HORIE, Y., & Suzuki, A. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.026 · Cited by 67
Identification of a gene-pathway associated with non-alcoholic steatohepatitis
Rubio, Á., Guruceaga, E., Vázquez–Chantada, M., Sandoval, J., Martínez‐Cruz, L. A., Segura, V., Sevilla, J., Podhorski, A., Corrales, F. J., Torres, L., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.021 · Cited by 56
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells
Caligiuri, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50058 · Cited by 52
García‐Ruíz, I., de la Torre, P., Díaz, T. C., Esteban, E., Fernández, I., Muñoz‐Yagüe, T., & Solis-Herruzo, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203368200 · Cited by 50
Peňa, A. D., Leclercq, I. A., Williams, J., & Farrell, G. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.025 · Cited by 50
Huang, W., Dedousis, N., & O'Doherty, R. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01449.2006 · Cited by 45
Carpentier, A. C., Patterson, B. W., Leung, N. M., & Lewis, G. F. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1867 · Cited by 41
Leptin and liver tissue repair: Do rodent models provide the answers?
Marra, F. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.002 · Cited by 38
Self-citationZoltowska, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00711-5 · Cited by 34
Nuclear Factor-κB in the Liver: Friend or Foe?
Schwabe, R. F., & Brenner, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.058 · Cited by 21
Thiazolidinediones and hepatic fibrosis: don’t wait too long
Marra, F. (2006) · Gut · doi:10.1136/gut.2005.085399 · Cited by 11
Self-citationLvjedde, T., Beraza, N., Loo, G., Nenci, A., Vos, R. D., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Journal of Hepatology · doi:10.1016/s0168-8278(07)61668-7 · Cited by 5
Cited by
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2300 · Cited by 554
Metadata
- Authors
- Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 14
- Issue
- 2
- Pages
- 72-81
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2039678693
- Cited by
- 425
- References
- 96
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.